Nicholas L Rider, Yingya Li, Aaron T Chin, Daniel V DiGiacomo, Cullen Dutmer, Jocelyn R Farmer, Kirk Roberts, Guergana Savova, Mei-Sing Ong
{"title":"Evaluating Large Language Model Performance to Support the Diagnosis and Management of Patients with Primary Immune Disorders.","authors":"Nicholas L Rider, Yingya Li, Aaron T Chin, Daniel V DiGiacomo, Cullen Dutmer, Jocelyn R Farmer, Kirk Roberts, Guergana Savova, Mei-Sing Ong","doi":"10.1016/j.jaci.2025.02.004","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Generative artificial intelligence (GAI) is transforming healthcare in a variety of ways; however, present utility of GAI for supporting clinicians in rare disease such as primary immune disorders (PI) is not well studied. Here we evaluate the ability of 6 state-of-the-art large language models (LLMs) for providing clinical guidance about PI.</p><p><strong>Objective: </strong>We sought to quantitatively and qualitatively measure the utility of current, open-source LLMs for diagnosing and providing helpful clinical decision support about PI.</p><p><strong>Methods: </strong>Five expert clinical immunologists provided 5 real-world (n=25), anonymized PI case vignettes via multi-turn prompting to 6 LLMs (OpenAI GPT-4o, Llama-3.1-8B-Instruct, Llama-3.1-70B-Instruct, Mistral-7B-Instruct-v0.3, Mistral-Large-Instruct-2407, and Mixtral-8x7B-Instruct-v0.1). We assessed the diagnostic accuracy of the LLMs and the quality of clinical reasoning using the Revised-IDEA (R-IDEA) score. Qualitative LLM assessment was made by immunologist narratives.</p><p><strong>Results: </strong>Performance accuracy (>88%) and R-IDEA scores (>=8) were superior for 3 models (GPT-4o, Llama-3.1-70B-Instruct, Mistral-Large-Instruct-2407), with GPT-4o achieving the highest diagnostic accuracy (96.2%). Conversely, the remaining 3 models fell below acceptable accuracy rates near 60% or worse and poor R-IDEA scores (<=0.55), with Mistral-7B-Instruct-v0.3 attaining the worst diagnostic accuracy (42.3%). Compared with the 3 best-performing LLMs, the 3 worst-performing LLMs received a substantially lower median R-IDEA score (p<0.001). Interclass correlation coefficient for R-IDEA score assignments varied substantially by LLM, ranging from good to poor agreement, and did not appear to correlate with either diagnostic accuracy or the median R-IDEA score. Qualitatively, immunologists identified several themes (e.g. correctness, differential diagnosis appropriateness, relative conciseness of explanations) of relevance to PI.</p><p><strong>Conclusions: </strong>LLM can support the diagnosis and management of PI; however, further tuning is needed to optimize LLMs for best practice recommendations.</p>","PeriodicalId":14936,"journal":{"name":"Journal of Allergy and Clinical Immunology","volume":" ","pages":""},"PeriodicalIF":11.4000,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Allergy and Clinical Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jaci.2025.02.004","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Generative artificial intelligence (GAI) is transforming healthcare in a variety of ways; however, present utility of GAI for supporting clinicians in rare disease such as primary immune disorders (PI) is not well studied. Here we evaluate the ability of 6 state-of-the-art large language models (LLMs) for providing clinical guidance about PI.
Objective: We sought to quantitatively and qualitatively measure the utility of current, open-source LLMs for diagnosing and providing helpful clinical decision support about PI.
Methods: Five expert clinical immunologists provided 5 real-world (n=25), anonymized PI case vignettes via multi-turn prompting to 6 LLMs (OpenAI GPT-4o, Llama-3.1-8B-Instruct, Llama-3.1-70B-Instruct, Mistral-7B-Instruct-v0.3, Mistral-Large-Instruct-2407, and Mixtral-8x7B-Instruct-v0.1). We assessed the diagnostic accuracy of the LLMs and the quality of clinical reasoning using the Revised-IDEA (R-IDEA) score. Qualitative LLM assessment was made by immunologist narratives.
Results: Performance accuracy (>88%) and R-IDEA scores (>=8) were superior for 3 models (GPT-4o, Llama-3.1-70B-Instruct, Mistral-Large-Instruct-2407), with GPT-4o achieving the highest diagnostic accuracy (96.2%). Conversely, the remaining 3 models fell below acceptable accuracy rates near 60% or worse and poor R-IDEA scores (<=0.55), with Mistral-7B-Instruct-v0.3 attaining the worst diagnostic accuracy (42.3%). Compared with the 3 best-performing LLMs, the 3 worst-performing LLMs received a substantially lower median R-IDEA score (p<0.001). Interclass correlation coefficient for R-IDEA score assignments varied substantially by LLM, ranging from good to poor agreement, and did not appear to correlate with either diagnostic accuracy or the median R-IDEA score. Qualitatively, immunologists identified several themes (e.g. correctness, differential diagnosis appropriateness, relative conciseness of explanations) of relevance to PI.
Conclusions: LLM can support the diagnosis and management of PI; however, further tuning is needed to optimize LLMs for best practice recommendations.
期刊介绍:
The Journal of Allergy and Clinical Immunology is a prestigious publication that features groundbreaking research in the fields of Allergy, Asthma, and Immunology. This influential journal publishes high-impact research papers that explore various topics, including asthma, food allergy, allergic rhinitis, atopic dermatitis, primary immune deficiencies, occupational and environmental allergy, and other allergic and immunologic diseases. The articles not only report on clinical trials and mechanistic studies but also provide insights into novel therapies, underlying mechanisms, and important discoveries that contribute to our understanding of these diseases. By sharing this valuable information, the journal aims to enhance the diagnosis and management of patients in the future.